Wen Loong Yeow

HIGH MORTALITY IN SCREENED PATIENTS WITH FUNCTIONAL MITRAL REGURGITATION AWAITING MITRACLIP PROCEDURE

There is a paucity of data of patients with severe functional mitral regurgitation (FMR) not treated with surgery. There is no data supporting surgery affects outcome in FMR. The MitraClip is a less invasive procedure, which may improve survival. As off September 2012, all consecutive FMR patients

EVALUATION OF MITRAL VALVE AREA AFTER MITRACLIP PROCEDURE: A REAL-TIME 3D TRANSESOPHAGEAL ECHOCARDIOGRAPHIC STUDY

Mitral valve area (MVA) decreases after MitraClip deployment. However, it may be difficult to accurately measure double orifice areas after the procedure by 2-dimensional (2D) echocardiography because orifices are located in different 2D planes (Figure, lower right). Our purpose was to determine the

PREOPERATIVE PULMONARY HYPERTENSION HAS AN ADVERSE EFFECT IN PATIENTS WITH FUNCTIONAL MITRAL REGURGITATION UNDERGOING THE MITRACLIP PROCEDURE

MitraClip (Abbott Vascular, Menlo Park, California) is an effective low risk transcatheter treatment option for the treatment of functional mitral regurgitation (FMR). Pulmonary hypertension (PH) is a predictor of adverse outcome following mitral valve surgery. However, the prognostic implications

TCT-795 Procedural success is improved with a 2nd MitraClip placement without additional complications

Suboptimal result of the MitraClip procedure (Abbott Vascular, Santa Clara, California) might be related to inadequate number of clips. In some cases of the MitraClip procedure, 2nd clip is required to be placed for residual mitral regurgitation (MR) after 1st clip placement. However the reports of